Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities - Wikidata - thesis-toulmin - TriplyDB

Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities

Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities

http://www.wikidata.org/entity/Q27023811

about

Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.Up-regulation of SNCA gene expression: implications to synucleinopathies A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.CpG site DNA methylation patterns reveal a novel regulatory element in the mouse prion protein gene.Parkinson's Disease: From Pathogenesis to Pharmacogenomics The role of microRNAs in toxicology.Epigenetic mechanisms in neurological and neurodegenerative diseases.Implications of DNA Methylation in Parkinson's Disease.Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings.Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.Global DNA methylation profiling of manganese-exposed human neuroblastoma SH-SY5Y cells reveals epigenetic alterations in Parkinson's disease-associated genes.Looking above but not beyond the genome for therapeutics in neurology and psychiatry: epigenetic proteins and RNAs find a new focus.Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells.Omics Approaches for Identifying Physiological Adaptations to Genome Instability in Aging.Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.Association of DNMT3b gene variants with sporadic Parkinson's disease in a Chinese Han population.Functional Restoration of Amyotrophic Lateral Sclerosis Patient-Derived Mesenchymal Stromal Cells Through Inhibition of DNA Methyltransferase.Acetylome in Human Fibroblasts From Parkinson's Disease Patients.

P2860

Q28088705-096B8CD7-25AD-4344-8EBB-CD32BF18B94F Q35978159-50D03E5B-C309-4157-B7EA-F849380DE3C1 Q37004246-0F68FFF1-8396-4331-9458-0C18AE217781 Q37341837-114AED2A-8C78-4BF9-A8BC-25644E9345F0 Q37621341-F59FE2E5-7E75-4FA4-AB08-74B02AD24C4A Q37729129-169E03C7-3747-43CA-8E40-86FCD113D0D6 Q38317697-80B5869D-BD02-4517-9AEB-ACFCDB1B5F15 Q38379396-61382FAF-19AE-419D-8447-46A707BFB245 Q38645698-AFBE776D-D95F-4409-837B-B44FF9A443E0 Q38686112-8558654D-B62F-44B9-BF08-0F12634890DB Q39096105-515C83D8-8F1D-4662-89F9-9A67B3B7E5D0 Q39134468-7D17149D-A14E-4B4B-A5AD-9EB29A8D3158 Q42937645-B3CA563B-60AC-4616-98F1-D6858652F35C Q45297735-C51015E2-1FCB-49E5-8393-CF003E3971A1 Q46283329-5CC5647B-B550-4C56-AD41-548299377A18 Q47097416-15E6ABF8-0789-4DC1-AF86-3FC372745005 Q47259835-01F7FB06-C0A6-4EA1-82CA-DFBB583914A8 Q47616651-5E0C5DEB-DB89-4A7B-B5D9-7FBDA938EBEC Q53176268-EBBC4B80-90BE-436F-B23A-5690FC272127 Q54112963-061B1F88-91DA-476B-97D3-BD5FFD92EF92

P2860

Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities

http://www.wikidata.org/entity/Q27023811

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@ast

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@en

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@nl

type

label

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@ast

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@en

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@nl

prefLabel

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@ast

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@en

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@nl

P1433

Q27023811-03B6C080-1EDE-4610-B588-84BA2C70F5D2

P1476

Q27023811-753055F5-D724-42A1-97C7-4AB7F7C4AE32

P2093

Q27023811-AFEDE64A-B692-4F15-84F7-6AACA5F7B467

Q27023811-CF792FE7-AB47-4050-A4BF-6FD43FECC8E8

P2860

Q27023811-00748E4A-7258-4608-9C9D-E5AEBC37D2B4

Q27023811-02192F56-8185-4AEE-9D95-B5F38C9A4243

Q27023811-0E875055-5452-40EA-BEB7-BDC138FF83DA

Q27023811-10CC1AF0-D2F2-48B6-8D85-0AE825C87B20

Q27023811-12830C0D-1835-46B7-91D2-F5FF09469117

Q27023811-12E08567-47F1-4B43-91B7-692C63AFC3A7

Q27023811-16E1CD58-CA8A-4DAB-923D-F896FD9B9449

Q27023811-18F3FC3B-5433-4921-8B12-E11E99AE37CF

Q27023811-2070B154-05D2-44DB-8745-41B52A552DDC

Q27023811-228B1150-7EDF-462A-89D4-FD28806F3630

P2888

Q27023811-A7502B29-B9C0-4DDB-B41E-50F033B3FDA3

P304

Q27023811-09FD8A1C-9400-4C00-98E0-B1AC7C7FD8C9

P31

Q27023811-33443225-96CB-4EFD-B418-5EE55981141F

P356

Q27023811-7FA2D286-0BBB-425F-A3BB-85E862F52720

P407

Q27023811-909D321C-360A-4C94-AF9D-4F486D918F86

P433

Q27023811-B434CCC8-908A-409F-93CC-24DA6D83DB47

P478

Q27023811-D2DCEEF8-9872-4FF8-9AB8-82EF2C5A0E15

P50

Q27023811-25147703-2C7F-4703-AB7D-EB08F20C03BD

P577

Q27023811-AAC63929-9E7C-4444-A00A-8067DA5A10CD

P6179

Q27023811-17A2613F-525A-4F43-82F3-1D16A40CA0E8

P698

Q27023811-44605C2D-483B-4352-B3A4-028B99E8A030

P921

Q27023811-CDF2E19C-8B6C-451A-A7B8-9FEB98CBF758

P932

Q27023811-88410E06-D497-471F-B53C-71AD84F73086

P356

S13311-013-0211-8

P1433

Neurotherapeutics

P1476

Epigenetic landscape of Parkin ...... sms and therapeutic modalities

@en

P2093

Bobby Thomas

http://www.w3.org/2001/XMLSchema#string

Shaista Tarannum

http://www.w3.org/2001/XMLSchema#string

P2860

A two-stage meta-analysis identifies several new loci for Parkinson's disease

alpha-Synuclein and neuronal cell death

The Changing Concept of Epigenetics

Occupational exposure to pesticides and Parkinson's disease: A systematic review and meta-analysis of cohort studies

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Kinase activity of mutant LRRK2 mediates neuronal toxicity

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

HDAC2 negatively regulates memory formation and synaptic plasticity.

Distinct DNA methylation changes highly correlated with chronological age in the human brain

P2888

s13311-013-0211-8

P304

698-708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-013-0211-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Navneet Ammal Kaidery

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008459934

http://www.w3.org/2001/XMLSchema#string

P698

24030213

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3805874

http://www.w3.org/2001/XMLSchema#string